The drug information sheets that the FDA requires companies to produce are living documents that get updated with new ...
In a complaint filed in a state court in Santa Rosa County on Thursday, Florida Attorney General James Uthmeier claimed the ...
Dominic Cipriano couldn't stop shaking. A drug dealer on the streets of Kensington had sold him a bag of what he thought was ...
Indian pharma exporters had for several months faced the rhetoric and threats from the Trump administration to impose tariffs ...
TipRanks on MSN
REGN, GMAB, ARWR: Which Healthcare Stock Is Best Buy Ahead of U.S. Drug Approvals This Nov?
Several pharmaceutical companies awaiting a decision from U.S. authorities on their drug applications are set to get them ...
Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.
Ingenus Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of ...
Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...
The Thanksgiving cost numbers Trump is touting come directly from Walmart, which is selling a $40 Thanksgiving basket ...
If Trump decides to go ahead and pursue a piece of Novo Nordisk, he would be under more public pressure to successfully lower ...
Watford Observer on MSN
‘Dishonest’ nurse struck off after falsifying patient records
A “dishonest” nurse has been struck off after she falsified patient records at a Hemel Hempstead care home. A misconduct ...
Navar A. Efficacy and safety of enlicitide, an oral PCSK9 inhibitor, for lowering LDL cholesterol in adults with or at-risk for ASCVD: the phase 3 CORALreef lipids trial. Presented at: AHA 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results